Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Economic Burden of Haematological Adverse Effects in Cancer Patients
- S. Y. Liou, J. Stephens, K. T. Carpiuc, W. Feng, M. Botteman, J. Hay
- Medicine
- Clinical drug investigation
- 2007
AbstractObjective: Patients receiving cancer treatments commonly experience haematological adverse effects (AEs) related to chemotherapy or molecularly targeted therapies, which may be associated… Expand
Clinical and economic burden of invasive fungal diseases in Europe: focus on pre-emptive and empirical treatment of Aspergillus and Candida species
- Ľ. Drgoňa, A. Khachatryan, +4 authors R. Barnes
- Biology, Medicine
- European Journal of Clinical Microbiology…
- 12 September 2013
Invasive fungal diseases (IFDs) have been widely studied in recent years, largely because of the increasing population at risk. Aspergillus and Candida species remain the most common causes of IFDs,… Expand
Economic burden of long-term complications of deep vein thrombosis after total hip replacement surgery in the United States.
- J. Caprini, M. Botteman, +5 authors A. Cohen
- Medicine
- Value in health : the journal of the…
- 2003
BACKGROUND
Estimates of the cost of long-term complications of a primary deep vein thrombosis (DVT), including the post-thrombotic syndrome (PTS) and recurrent venous thromboembolism (VTE), may be… Expand
Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes
- J. Baddley, J. Stephens, X. Ji, X. Gao, H. Schlamm, M. Tarallo
- Medicine
- BMC Infectious Diseases
- 23 January 2013
BackgroundFew data are available regarding the epidemiology of invasive aspergillosis (IA) in ICU patients. The aim of this study was to examine epidemiology and economic outcomes (length of stay,… Expand
Short- and long-term effects of acute myeloid leukemia on patient health-related quality of life.
- A. Redaelli, J. Stephens, Suzanne Brandt, M. Botteman, C. Pashos
- Medicine
- Cancer treatment reviews
- 1 February 2004
OBJECTIVES
Patients with acute myeloid leukemia (AML) may receive aggressive therapies (e.g., chemotherapy and bone marrow transplantation (BMT)) that are thought to significantly affect HRQL.… Expand
Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term…
- M. Botteman, J. Caprini, +4 authors A. Cohen
- Medicine
- Clinical therapeutics
- 1 November 2002
BACKGROUND
Premature death due to pulmonary embolism is a short-term complication of deep vein thrombosis (DVT). The long-term clinical course after DVT can be further complicated by excess… Expand
Perioperative myocardial ischemic injury in high-risk vascular surgery patients: incidence and clinical significance in a prospective clinical trial.
- W. Mackey, L. Fleisher, +5 authors J. Stephens
- Medicine
- Journal of vascular surgery
- 1 March 2006
OBJECTIVE
The purpose of this study was to assess prospectively the incidence, health care resource utilization, and economic burden associated with perioperative myocardial ischemic injury (PMII) in… Expand
Rising United States Hospital Admissions for Acute Bacterial Skin and Skin Structure Infections: Recent Trends and Economic Impact
- K. Kaye, D. Patel, J. Stephens, A. Khachatryan, Ayush Patel, K. Johnson
- Medicine
- PloS one
- 24 November 2015
Background The number of ambulatory patients seeking treatment for skin and skin structure infections (SSSI) are increasing. The objective of this study is to determine recent trends in hospital… Expand
The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors.
- J. Stephens, B. Laskin, C. Pashos, B. Peña, J. Wong
- Medicine
- Rheumatology
- 1 November 2003
Pain has been recognized as a problem of global proportions, and postoperative pain is one of the most common types of pain. Postoperative pain is acute and, although it is preventable and/or… Expand
Economic impact of antidiabetic medications and glycemic control on managed care organizations: a review of the literature.
- J. Stephens, M. Botteman, J. Hay
- Medicine
- Journal of managed care pharmacy : JMCP
- 1 March 2006
OBJECTIVE
To review the recent literature (January 2000-November 2005) regarding the impact of antidiabetic medications and glycemic control on the overall costs of care for patients with diabetes in… Expand